• Disclosure
  • Privacy Policy
  • DMCA Policy
  • CCPA
  • Medical Disclaimer
  • Contact
  • About
Thursday, June 30, 2022
Maryland Digital News
  • Home
  • US
  • Business
  • World
  • Baltimore
  • Columbia
  • Germantown
  • Waldorf
  • Silver Spring
  • Frederick
  • Press Releases
  • Videos
No Result
View All Result
  • Home
  • US
  • Business
  • World
  • Baltimore
  • Columbia
  • Germantown
  • Waldorf
  • Silver Spring
  • Frederick
  • Press Releases
  • Videos
No Result
View All Result
No Result
View All Result
Home Business

Pfizer And BioNTech To Ask FDA To Authorize COVID-19 Booster For Kids As Young As 5

by NewsReporter
April 14, 2022
in Business
Reading Time: 4 mins read
pfizer-and-biontech-to-ask-fda-to-authorize-covid-19-booster-for-kids-as-young-as-5
Share on FacebookShare on Twitter

Pfizer and BioNTech plan to ask the Food and Drug Administration to clear a third dose of their COVID-19 vaccine for children as young as 5, the companies announced Wednesday, citing trial results showing a “robust response” of antibodies in this age group after the booster shot. 

In the trial, 140 children ages 5 to 11 years old were given a third dose of the Pfizer-BioNTech COVID-19 vaccine six months after receiving their second shot. Blood drawn from the children showed a six-fold increase in antibodies compared to the amount seen one month after the second dose, indicating “a strong immune response in this age group,” the companies said.

A subset of antibodies from the children in the trial were also tested against the Omicron variant. Those 30 samples had a strong enough antibody response to neutralize the variant, with a “robust response” regardless of whether the children had previously survived a case of COVID-19, the companies said.

“Pfizer and BioNTech plan to submit a request for Emergency Use Authorization (EUA) of a booster dose for children ages 5 through 11 in the U.S. in the coming days,” the companies said in a release. 

While vaccine effectiveness against hospitalization remained relatively high during the Omicron wave, the risk of breakthrough infections among Americans who had received only two doses of a COVID-19 vaccine soared among all age groups — including children. 

According to data presented last week by a Centers for Disease Control and Prevention official, two doses were as little as 24% effective at curbing infection in children 5 to 11 years old during the Omicron wave.

If Pfizer and BioNTech’s request is greenlighted by the FDA and approved by the CDC, only a small handful of children would likely initially be eligible for the booster. According to the CDC, just 28% of Americans ages 5 to 11 have been fully vaccinated since the agency formally recommended the shots for that age group in early November. 

Federal officials have openly expressed frustration with the lagging pace of vaccinations. The CDC found in March that around 4 in10 parents of children ages 5 to 11 probably would not have their kids vaccinated.

However, the announcement also comes as concerns are mounting among some health experts and officials of a new wave of cases in the coming months driven by the BA.2 subvariant of Omicron. The nationwide pace of COVID-19 cases and hospitalizations has begun to accelerate in recent weeks, with the largest upticks in the Northeast regions, where the subvariant first became dominant. 

“All that stuff you hear about, don’t worry about kids, let them get infected, is a bunch of nonsense. There have been about 12 million cases in kids, there have been over 120,000 hospitalizations,” Dr. Anthony Fauci said Monday, in a lecture at Uniformed Services University.

“We really need to put that myth to sleep that we don’t need to protect the children now,” Fauci added. 

No data for children under 5 

The release does not include widely-anticipated data on the immune response in children under 5. The FDA in February postponed plans to weigh authorizing two doses for kids in that age group, pledging to return to the issue after the companies submitted data on the subject. 

“We at FDA really understand the urgency that people feel about wanting to get the youngest children vaccinated. We also understand that this is the age range when people are most concerned about potential side effects and the potential safety of vaccines,” Dr. Peter Marks, the FDA’s top vaccines official, told reporters last month. 

Data on three doses in children under 5 is expected in the “coming weeks,” according to a Pfizer spokesperson.

“FDA has a lot of familiarity with these data sets and so they could act quickly on them. Assuming the data comes out in April, as is expected, I think the agency could potentially act in May,” former FDA Commissioner Dr. Scott Gottlieb, who sits on Pfizer’s board of directors, told “Face the Nation” on Sunday. 

Moderna has also released “positive interim data” from trials of just two doses of its vaccine in children as young as 6 months, with plans to seek the FDA’s authorization in the coming weeks. 

“My hunch is it will slip a little bit because that sense of urgency will have dissipated because infection levels will be relatively low as we get into the spring,” added Gottlieb. 

    In:

  • COVID-19 Vaccine
  • COVID-19

Alexander Tin

CBS News reporter covering public health and the pandemic.

Read More Here

Related Posts

netflix-subscribers-in-russia-launch-class-action-for-loss-of-service

Netflix Subscribers In Russia Launch Class Action For Loss Of Service

by NewsReporter
April 13, 2022
0

Russian Netflix users are suing the streaming firm for suspending its service as a result of Vladimir Putin’s invasion of Ukraine.Netflix, which has only about 1 million subscribers in Russia, suspended its services in March and has halted the development and acquisition of all Russian-made or commissioned TV shows and...

did-us-inflation-peak-in-march?-americans-are-concerned

Did US Inflation Peak In March? Americans Are Concerned

by NewsReporter
April 12, 2022
0

A version of this story first appeared in CNN Business' Before the Bell newsletter. Not a subscriber? You can sign up right here. You can listen to an audio version of the newsletter by clicking the same link.New York (CNN Business)Americans have been living with soaring prices for months. New inflation data set...

buffalo-officers-who-shoved-elderly-blm-protester-cleared-by-arbitrator

Buffalo Officers Who Shoved Elderly BLM Protester Cleared By Arbitrator

by NewsReporter
April 11, 2022
0

An arbitrator has ruled that two Buffalo police officers didn't violate the department's use-of-force guidelines when they pushed a 75-year-old protester to the ground in June 2020 during racial injustice protests following the murder of George Floyd in Minneapolis. The episode drew national attention when a news crew captured video ...

putin-appoints-a-'well-known-bombardier'-to-command-the-russian-army-in-ukraine-after-its-mauling-outside-kyiv

Putin Appoints A 'well-Known Bombardier' To Command The Russian Army In Ukraine After Its Mauling Outside Kyiv

by NewsReporter
April 10, 2022
0

Russia has appointed General Alexander Dvornikov to lead its Ukraine invasion, reports say. Dvornikov became the first commander of the Russian Armed Forces in Syria during Russia's 2015 intervention. The experienced general is reportedly tasked with "improving coordination between Russian forces." Loading Something is loading. Russia is believed to have...

Maryland Digital News

© 2021 Maryland Digital News

Navigate Site

  • Disclosure
  • Privacy Policy
  • DMCA Policy
  • CCPA
  • Medical Disclaimer
  • Contact
  • About

Follow Us

No Result
View All Result
  • Home
  • About
  • DMCA Policy
  • Medical Disclaimer
  • Privacy Policy
  • Disclosure
  • CCPA
  • Terms of Use

© 2021 Maryland Digital News

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT